ecancer

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

17 Feb 2022

Tumour agnostic treatments in GI cancer

Dr Nicola Normanno and Dr Katja Schmitz

1 Feb 2022

Early treatment discontinuation and early oxaliplatin discontinuation for stage III colorectal cancer

Dr Claire Gallois - Hôpitaux Universitaires Paris-Ouest, Paris, France

27 Jan 2022

Comparing two chemo regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced oesophageal cancer

Dr Ken Kato - National Cancer Center Hospital, Tokyo, Japan

25 Jan 2022

Nivo + chemo vs chemo as first-line treatment for advanced GC/GEJC/EAC

Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan

20 Jan 2022

OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more

Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla Karim, Dr Fumiko Chino, Dr Narjust Duma & Dr Nicole Kuderer

19 Jan 2022

OncoAlert Colloquium Day 4: GI oncology and EONS

Dr Cathy Eng, Dr Yelena Janjigian, Ms Stacy Hurt, Ms Allison Rosen, Dr Mark Lewis, Dr Nina Niu Sanford, Mr Johan de Munter & Dr Merel Van Klinken

19 Jan 2022

OncoAlert and ecancer weekly round up for October 11th - October 16, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

18 Oct 2021

Cancer Health Disparities Special Issue - Editorial

Prof Folakemi Odedina - University of Florida, Tampa, USA

14 Oct 2021

Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatment for gastric cancers

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA

14 Oct 2021

Pathogenesis of colon adenocarcinoma in Kerala, India

Dr Prasanth Ariyannur - Amrita Institute of Medical Sciences and Research Center, Kochi India

12 Oct 2021

Radioembolisation with chemotherapy for colorectal liver metastases

Dr Mary Mulcahy - Northwestern Memorial Hospital, Chicago, USA

28 Sep 2021

More from ecancer